Total Payments
$14,797
2024 Payments
$1,871
Companies
49
Transactions
511
Medicare Patients
12,647
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$9,653 (65.2%)
Other$4,834 (32.7%)
Education$310.52 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,653 | 487 | 65.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,834 | 19 | 32.7% |
| Education | $310.52 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $5,018 | 23 | $0 (2022) |
| ABBVIE INC. | $1,177 | 63 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,123 | 71 | $0 (2024) |
| Janssen Biotech, Inc. | $782.44 | 32 | $0 (2024) |
| Lilly USA, LLC | $539.12 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $481.98 | 26 | $0 (2024) |
| PFIZER INC. | $479.08 | 24 | $0 (2024) |
| Incyte Corporation | $475.06 | 19 | $0 (2024) |
| MAYNE PHARMA INC. | $415.68 | 23 | $0 (2022) |
| LEO Pharma Inc. | $413.36 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,871 | 82 | ABBVIE INC. ($304.20) |
| 2023 | $2,060 | 93 | Janssen Biotech, Inc. ($363.70) |
| 2022 | $3,039 | 85 | Allergan, Inc. ($1,385) |
| 2021 | $4,300 | 52 | Allergan, Inc. ($3,494) |
| 2020 | $656.24 | 33 | AbbVie Inc. ($79.91) |
| 2019 | $811.52 | 54 | Galderma Laboratories, L.P. ($156.88) |
| 2018 | $1,075 | 61 | Galderma Laboratories, L.P. ($255.99) |
| 2017 | $984.07 | 51 | Galderma Laboratories, L.P. ($179.25) |
All Payment Transactions
511 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.46 | General |
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.53 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.53 | General |
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.85 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.59 | General |
| 08/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,556 | 6,606 | $2.4M | $640,455 |
| 2022 | 30 | 3,108 | 5,875 | $1.9M | $501,766 |
| 2021 | 32 | 3,236 | 5,901 | $1.7M | $557,192 |
| 2020 | 29 | 2,747 | 4,618 | $1.4M | $468,570 |
Total Patients
12,647
Total Services
23,000
Medicare Billing
$2.2M
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 260 | 331 | $652,411 | $185,864 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 658 | 928 | $238,292 | $66,496 | 27.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 103 | 143 | $172,794 | $56,242 | 32.5% |
| Q4229 | Cogenex amniotic membrane, per square centimeter | Office | 2023 | 12 | 174 | $136,117 | $38,757 | 28.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 314 | 379 | $128,689 | $36,760 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 545 | 782 | $154,547 | $33,603 | 21.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 120 | 130 | $117,036 | $30,898 | 26.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 51 | 53 | $98,367 | $29,324 | 29.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 276 | 332 | $101,891 | $26,758 | 26.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 113 | 120 | $112,416 | $20,150 | 17.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 408 | 2,474 | $49,851 | $15,521 | 31.1% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 17 | 17 | $48,867 | $14,931 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 124 | $44,708 | $12,709 | 28.4% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 71 | 74 | $62,771 | $12,052 | 19.2% |
| 15220 | Full thickness skin graft to scalp, arms, or legs, 20.0 sq cm or less | Office | 2023 | 16 | 16 | $35,831 | $11,517 | 32.1% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 39 | 39 | $35,931 | $7,255 | 20.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 33 | 44 | $21,944 | $6,608 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $20,030 | $5,422 | 27.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 38 | 40 | $28,810 | $4,769 | 16.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 39 | 39 | $14,236 | $4,395 | 30.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 81 | $13,120 | $3,734 | 28.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 22 | $11,575 | $2,805 | 24.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 45 | 53 | $8,067 | $2,557 | 31.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 25 | $12,811 | $2,052 | 16.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 13 | $10,609 | $1,718 | 16.2% |
About Dr. Thomas Yu, MD
Dr. Thomas Yu, MD is a MOHS-Micrographic Surgery healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619963162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Yu, MD has received a total of $14,797 in payments from pharmaceutical and medical device companies, with $1,871 received in 2024. These payments were reported across 511 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,653).
As a Medicare-enrolled provider, Yu has provided services to 12,647 Medicare beneficiaries, totaling 23,000 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Bethesda, MD
- Active Since 09/21/2005
- Last Updated 05/03/2024
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1619963162
Products in Payments
- DUPIXENT (Biological) $635.17
- TREMFYA (Drug) $606.24
- TALTZ (Drug) $517.51
- EUCRISA (Drug) $448.54
- ORACEA (Drug) $437.13
- OPZELURA (Drug) $390.06
- Otezla (Drug) $377.29
- RINVOQ (Biological) $347.35
- ENSTILAR (Drug) $316.46
- SKYRIZI (Biological) $311.18
- COSENTYX (Biological) $304.58
- DORYX (Drug) $240.64
- AKLIEF (Drug) $237.06
- Humira (Biological) $221.48
- SPEVIGO (Drug) $203.42
- VTAMA (Drug) $177.90
- COSENTYX (Drug) $177.40
- JUBLIA (Drug) $147.54
- HUMIRA (Biological) $132.24
- REMICADE (Biological) $124.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Bethesda
Dr. Mark Welch, M.d, M.D
MOHS-Micrographic Surgery — Payments: $291.71
MOHS-Micrographic Surgery $291.71
Dr. Jeffrey Lackey, M.d, M.D
MOHS-Micrographic Surgery — Payments: $124.44
MOHS-Micrographic Surgery $124.44
Dr. Andrew Montemarano, D.o, D.O
MOHS-Micrographic Surgery — Payments: $16.35
MOHS-Micrographic Surgery $16.35